Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | FPR2 | P25090 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.30 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27810521 | 0.81 | BTK (0.36) | SMN1; SMN2RECQL | |
| SCHEMBL27810580 | 0.81 | SMN1; SMN2 (0.31) | SMN1; SMN2RECQL | |
| SCHEMBL27779427 | 0.78 | MAPK10 (0.34) | SMN1; SMN2FPR2PDK1PDK2PDK3 | |
| SCHEMBL27726473 | 0.77 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL27726471 | 0.74 | ADRB2 (0.31) | SMN1; SMN2 | |
| SCHEMBL4548405 | 0.74 | SMN1; SMN2 (0.43) | SMN1; SMN2RECQL | |
| SCHEMBL28784554 | 0.73 | SMN1; SMN2 (0.38) | SMN1; SMN2 | |
| SCHEMBL27213267 | 0.73 | — | — | |
| SCHEMBL10246306 | 0.73 | LMNA (0.31) | — | |
| SCHEMBL28457543 | 0.72 | KDM4E (0.39) | SMN1; SMN2FPR2PDK1PDK2PDK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101808666-A | Combination of antimitotic and lasokinase inhibitors as anticancer therapy | SCHERING CORP | 2010-08-18 | — | — | CN | disclosed |